A. (2006). Medical costs and medication use in women with interstitial cystitis. J Urol, 175 Suppl, 94-95. :Clemens, J. Q., Meenan, R. T., O’Keeffe-Rosetti, M. C., Gao, S. Y., & Calhoun, E. A. (2006). Medical costs and medication use in women with interstitial cystitis...
Medication non adherence in patients leads to substantial worsening of disease, death and increased health care costs. A variety of factors are likely to ... Jimmy,Beena,Jose - 《Oman Medical Journal》 被引量: 163发表: 2011年 Clinical and economic consequences of medication non-adherence in th...
However, if non-adherence is to be more effectively addressed, other components of the healthcare and pharmaceutical industries must also take responsibility. SUMMARY: Treatment non-adherence compromises treatment effectiveness and drives up the healthcare costs related to asthma and other chronic ...
The duloxetine and pregabalin cohorts were constructed via propensity score stratification with similar demographics, co-morbid medical conditions, pre-index healthcare utilization and costs, and prior treatment patterns. Medication possession ratio (MPR), proportion of patients with MPR≥0.8 and health...
Treatment of MOH includes the use of headache preventive therapies, but essential to success is eliminating the cause, by reducing the frequency of use of acute headache medication, and perhaps withdrawing the overused medication altogether. Appropriate treatment is usually highly effective, leading to ...
Medication use and health care costs have increased dramatically during the previous decade in the United States. Adherence to medication therapy often is a critical aspect of medical treatment, particularly the treatment of chronic conditions such as diabetes and hypertension. Despite the importance of...
24 This cost is seen in direct medical costs, in the indirect costs of decreased productivity and disability, and in the costs of obesity and diabetes-related complications such as renal failure, gestational diabetes, and cardiac disease. Thus, the current report has implications not only for ...
Policymakers, stakeholders, and health plan decision makers may consider this cost analysis, since they need to know how drug costs are being allocated. Moreover, information about costs and use of pain medications is valuable for the practitioner making individual patient care decisions, as well ...
Medication-assisted treatment Sorry, something went wrong. Please try again and make sure cookies are enabledReferences Aos et al., 2006 S. Aos, M. Miller, E. Drake Evidence-based public policy options to reduce future prison construction, criminal justice costs, and crime rates, Washington Stat...
Impact of appropriate pharmaceutical therapy for chronic conditions on direct medical costs and workplace productivity: a review of the literature. Dis Manag. 2004;7(1):61-75. doi:10.1089/109350704322919005 PubMedGoogle ScholarCrossref 5. Schiavoni KH, Lehmann LS, ...